Literature DB >> 6051332

Characterization of anthrax toxin.

M H Wilkie, M K Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6051332

Source DB:  PubMed          Journal:  Fed Proc        ISSN： 0014-9446


× No keyword cloud information.
  5 in total

1.  Serology and anthrax in humans, livestock and Etosha National Park wildlife.

Authors:  P C Turnbull; M Doganay; P M Lindeque; B Aygen; J McLaughlin
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

2.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.

Authors:  J W Ezzell; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Elaboration of Bacillus anthracis antigens in a new, defined culture medium.

Authors:  J D Ristroph; B E Ivins
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.